BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17509623)

  • 1. Cytotoxicity and mutagenicity of dibenzo[a,l]pyrene and (+/-)-dibenzo[a,l]pyrene-11,12-dihydrodiol in V79MZ cells co-expressing either hCYP1A1 or hCYP1B1 together with human glutathione-S-transferase A1.
    Kushman ME; Kabler SL; Ahmad S; Doehmer J; Morrow CS; Townsend AJ
    Mutat Res; 2007 Nov; 624(1-2):80-7. PubMed ID: 17509623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and mutagenicity of 5-methylchrysene and its 1,2-dihydrodiol in V79MZ cells modified to express human CYP1A1 or CYP1B1, in the presence or absence of human GSTP1 coexpression.
    Ahmad S; Kabler SL; Rudd L; Amin S; Doehmer J; Morrow CS; Townsend AJ
    Toxicol Lett; 2008 Dec; 183(1-3):99-104. PubMed ID: 18992797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective efficacy of hGSTM1-1 against B[a]P and (+)- or (-)-B[a]P-7,8-dihydrodiol cytotoxicity, mutagenicity, and macromolecular adducts in V79 cells coexpressing hCYP1A1.
    Kushman ME; Kabler SL; Ahmad S; Doehmer J; Morrow CS; Townsend AJ
    Toxicol Sci; 2007 Sep; 99(1):51-7. PubMed ID: 17525473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential protection by human glutathione S-transferase P1 against cytotoxicity of benzo[a]pyrene, dibenzo[a,l]pyrene, or their dihydrodiol metabolites, in bi-transgenic cell lines that co-express rat versus human cytochrome P4501A1.
    Kabler SL; Seidel A; Jacob J; Doehmer J; Morrow CS; Townsend AJ
    Chem Biol Interact; 2009 May; 179(2-3):240-6. PubMed ID: 19330882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of human glutathione S-transferase P1 confers resistance to benzo[a]pyrene or benzo[a]pyrene-7,8-dihydrodiol mutagenesis, macromolecular alkylation and formation of stable N2-Gua-BPDE adducts in stably transfected V79MZ cells co-expressing hCYP1A1.
    Kushman ME; Kabler SL; Fleming MH; Ravoori S; Gupta RC; Doehmer J; Morrow CS; Townsend AJ
    Carcinogenesis; 2007 Jan; 28(1):207-14. PubMed ID: 16885195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
    Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
    Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
    Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
    Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
    Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
    Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human cytochrome p450 1b1 further clarifies its role in the activation of dibenzo[a,l]pyrene in cells in culture.
    Mahadevan B; Luch A; Atkin J; Haynes M; Nguyen T; Baird WM
    J Biochem Mol Toxicol; 2007; 21(3):101-9. PubMed ID: 17623886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a human lymphoblastoid cell line constitutively expressing human CYP1B1 cDNA: substrate specificity with model substrates and promutagens.
    Crespi CL; Penman BW; Steimel DT; Smith T; Yang CS; Sutter TR
    Mutagenesis; 1997 Mar; 12(2):83-9. PubMed ID: 9106248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
    Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
    Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor formation in the neonatal mouse bioassay indicates that the potent carcinogen dibenzo[def,p]chrysene (dibenzo[a,l]pyrene) is activated in vivo via its trans-11,12-dihydrodiol.
    Platt KL; Dienes HP; Tommasone M; Luch A
    Chem Biol Interact; 2004 Jun; 148(1-2):27-36. PubMed ID: 15223354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.
    Buters JT; Mahadevan B; Quintanilla-Martinez L; Gonzalez FJ; Greim H; Baird WM; Luch A
    Chem Res Toxicol; 2002 Sep; 15(9):1127-35. PubMed ID: 12230405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the metabolic competency of glutathione S-transferases using genetically modified cell lines.
    Townsend AJ; Kabler SL; Doehmer J; Morrow CS
    Toxicology; 2002 Dec; 181-182():265-9. PubMed ID: 12505323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.
    Kim JH; Stansbury KH; Walker NJ; Trush MA; Strickland PT; Sutter TR
    Carcinogenesis; 1998 Oct; 19(10):1847-53. PubMed ID: 9806168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenicity of C24H14 PAH in human cells expressing CYP1A1.
    Durant JL; Lafleur AL; Busby WF; Donhoffner LL; Penman BW; Crespi CL
    Mutat Res; 1999 Oct; 446(1):1-14. PubMed ID: 10613181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the species-specific biotransformation of dibenzo[a,l]pyrene.
    Schober W; Luch A; Soballa VJ; Raab G; Stegeman JJ; Doehmer J; Jacob J; Seidel A
    Chem Biol Interact; 2006 May; 161(1):37-48. PubMed ID: 16581046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of stably transfected murine glutathione S-transferase A3-3 protects against nucleic acid alkylation and cytotoxicity by aflatoxin B1 in hamster V79 cells expressing rat cytochrome P450-2B1.
    Fields WR; Morrow CS; Doehmer J; Townsend AJ
    Carcinogenesis; 1999 Jun; 20(6):1121-5. PubMed ID: 10357798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.